The Only Complete Online Marketing Firm
Monday, June 1, 2015
ASCO: Survival Benefit With Docetaxel in High-Risk Prostate Cancer
(MedPage Today) -- For the first time, adjuvant chemotherapy improves survival in the localized setting
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment